Combination of artificial intelligence-based endoscopy and miR148a methylation for gastric indefinite dysplasia diagnosis.

Journal: Journal of clinical laboratory analysis
Published Date:

Abstract

BACKGROUND AND AIM: Gastrointestinal endoscopy and biopsy-based pathological findings are needed to diagnose early gastric cancer. However, the information of biopsy specimen is limited because of the topical procedure; therefore, pathology doctors sometimes diagnose as gastric indefinite for dysplasia (GIN).

Authors

  • Yoshiyuki Watanabe
    Department of Future Diagnostic Radiology, Osaka University Graduate School of Medicine.
  • Ritsuko Oikawa
    Division of Gastroenterology and Hepatology, Department of Internal Medicine, St. Marianna University School of Medicine, Kanagawa, Japan.
  • Shuhei Agawa
    Division of Gastroenterology, Department of Internal Medicine, Nippon Medical School, Tokyo, Japan.
  • Yasumasa Matsuo
    Division of Gastroenterology and Hepatology, Department of Internal Medicine, St. Marianna University School of Medicine, Kanagawa, Japan.
  • Ichiro Oda
    Endoscopy Division, National Cancer Center Hospital, Tokyo, Japan.
  • Seiji Futagami
    Division of Gastroenterology, Department of Internal Medicine, Nippon Medical School, Tokyo, Japan.
  • Hiroyuki Yamamoto
    Department of Pediatrics, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  • Tomohiro Tada
    AI Medical Service Inc Tokyo Japan.
  • Fumio Itoh
    Division of Gastroenterology and Hepatology, Department of Internal Medicine, St. Marianna University School of Medicine, Kanagawa, Japan.